Gabriel N. Hortobagyi, MD, is a professor of medicine in the Department of
Breast Medical Oncology and the Nellie B. Connally Chair in Breast Cancer
at The University of Texas MD Anderson Cancer Center. He also is program
director of the Susan G. Komen Interdisciplinary Breast Fellowship Program
at MD Anderson. His work and accomplishments include:
Developed and promoted the use of presurgical chemotherapy in
patients with large tumors, reducing the tumors to 50% of their size
prior to surgery and enabling subsequent surgical removal
Involved in the drug development of anthracyclines and taxanes in
breast cancer therapy
Established the role of bisphosphonates in the management of bone
metastases from breast cancer
Developed gene therapy approaches to breast cancer, and played
a role in the initial development of gene expression profiling and its
prognostic and predictive application in breast cancers
Past president of the American Society of Clinical Oncology
Chair of the Southwest Oncology Group since 2007
Recipient of numerous awards, including the 2012 William L. McGuire
Award and Memorial Lecture, CTCR-AACR San Antonio Breast Cancer Symposium,
and the 1997 Brinker International Award for Clinical Research